ArticleCancer drug resistance (Alhambra, Calif.)2025

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer.

Juncheng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.